ORAMED PHARMACEUTICALS INC. (ORMP) Insider Trading

Name: ORAMED PHARMACEUTICALS INC. (ORMP) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Gabay Avraham (Chief Financial Officer): Sale of 20,000 shares, $90.2K.

Get alerted when insiders trade ORMP

Email address

Loading company data...

Loading company details...